Two  	Two  	 CD	O
novel  	novel  	 NN	O
HSD3B2  	HSD3B2  	 CD	O
missense  	missense  	 CD	O
mutations  	mutations  	 NNS	O
with  	with  	 IN	O
diverse  	diverse  	 JJ	B-NP
residual  	residual  	 JJ	I-NP
enzymatic  	enzymatic  	 JJ	I-NP
activities  	activities  	 NNS	I-NP
for  	for  	 IN	O
Δ5-steroids  	Δ5-steroids  	 FW	O
Classical  	Classical  	 FW	O
3β-hydroxysteroid  	3β-hydroxysteroid  	 FW	O
dehydrogenase  	dehydrogenase  	 FW	O
( 	( 	 -LRB-	O
3β-HSD 	3β-HSD 	 NNP	O
)  	)  	 -RRB-	O
deficiency  	deficiency  	 NN	O
( 	( 	 -LRB-	O
3β-HSDD 	3β-HSDD 	 NNP	O
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
caused  	caused  	 VBN	O
by  	by  	 IN	O
loss-of-function  	loss-of-function  	 JJ	B-NP
mutations  	mutations  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
HSD3B2  	HSD3B2  	 JJ	O
gene  	gene  	 NN	O
encoding  	encoding  	 NN	O
type  	type  	 NN	O
II  	II  	 NNP	O
3β-HSD 	3β-HSD 	 NNP	O
,  	,  	 ,	O
which  	which  	 WDT	O
has  	has  	 VBZ	O
a  	a  	 DT	O
key  	key  	 JJ	B-NP
role  	role  	 NN	I-NP
in  	in  	 IN	O
steroid  	steroid  	 JJ	B-NP
biosynthesis 	biosynthesis 	 NN	I-NP
,  	,  	 ,	O
converting  	converting  	 VBG	B-NP
Δ5-steroids  	Δ5-steroids  	 CD	I-NP
to  	to  	 TO	O
Δ4-steroids  	Δ4-steroids  	 CD	B-NP
in  	in  	 IN	O
adrenal  	adrenal  	 JJ	B-NP
glands  	glands  	 NN	I-NP
and  	and  	 CC	O
gonads 	gonads 	 NN	B-NP
.  	.  	 .	O
A  	A  	 DT	O
patient  	patient  	 NN	O
( 	( 	 -LRB-	O
46 	46 	 CD	O
,  	,  	 ,	O
XX 	XX 	 NNP	O
)  	)  	 -RRB-	O
was  	was  	 VBD	O
found  	found  	 VBN	O
to  	to  	 TO	O
have  	have  	 VB	O
elevated  	elevated  	 JJ	O
17-hydroxyprogesterone  	17-hydroxyprogesterone  	 NNP	O
( 	( 	 -LRB-	O
17-OHP 	17-OHP 	 NNP	O
)  	)  	 -RRB-	O
[ 	[ 	 -LRB-	O
203  	203  	 CD	O
nmol 	nmol 	 CD	B-NP
/ 	/ 	 CD	I-NP
l  	l  	 NNS	I-NP
( 	( 	 -LRB-	O
normal  	normal  	 JJ	B-NP
range 	range 	 NN	I-NP
:  	:  	 :	O
2·94  	2·94  	 FW	O
±  	±  	 FW	O
0·9  	0·9  	 FW	O
nmol 	nmol 	 FW	B-NP
/ 	/ 	 FW	I-NP
l 	l 	 FW	I-NP
) 	) 	 -RRB-	O
]  	]  	 -RRB-	O
by  	by  	 IN	O
newborn  	newborn  	 JJ	O
screening 	screening 	 NN	O
.  	.  	 .	O
Endocrinological  	Endocrinological  	 JJ	B-NP
examination  	examination  	 NN	I-NP
revealed  	revealed  	 VBD	O
dramatically  	dramatically  	 RB	O
increased  	increased  	 VBD	B-NP
Δ5-steroids  	Δ5-steroids  	 CD	I-NP
[ 	[ 	 -LRB-	O
e.g.  	e.g.  	 FW	O
17-OH  	17-OH  	 FW	O
pregnenolone 	pregnenolone 	 FW	O
:  	:  	 :	O
910  	910  	 CD	O
nmol 	nmol 	 CD	B-NP
/ 	/ 	 CD	I-NP
l  	l  	 NNS	I-NP
( 	( 	 -LRB-	O
normal  	normal  	 JJ	B-NP
range 	range 	 NN	I-NP
:  	:  	 :	O
12·6  	12·6  	 FW	O
±  	±  	 FW	O
10·5  	10·5  	 FW	O
nmol 	nmol 	 FW	B-NP
/ 	/ 	 FW	I-NP
l 	l 	 FW	I-NP
) 	) 	 -RRB-	O
] 	] 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
patient  	patient  	 NN	O
had  	had  	 VBD	O
virilization  	virilization  	 VBN	O
of  	of  	 IN	O
external  	external  	 JJ	B-NP
genitalia  	genitalia  	 NN	I-NP
with  	with  	 IN	O
labial  	labial  	 JJ	B-NP
fusion 	fusion 	 NN	I-NP
,  	,  	 ,	O
suggesting  	suggesting  	 VBG	O
classical  	classical  	 JJ	O
3β-HSDD 	3β-HSDD 	 NN	O
.  	.  	 .	O
Consistent  	Consistent  	 JJ	O
with  	with  	 IN	O
the  	the  	 DT	O
endocrinological  	endocrinological  	 JJ	B-NP
data 	data 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
patient  	patient  	 NN	O
was  	was  	 VBD	O
a  	a  	 DT	O
compound  	compound  	 JJ	O
heterozygote  	heterozygote  	 NN	B-NP
for  	for  	 IN	O
two  	two  	 CD	O
novel  	novel  	 NN	B-NP
missense  	missense  	 NN	I-NP
mutations  	mutations  	 NNS	I-NP
( 	( 	 -LRB-	O
p.Y190C  	p.Y190C  	 NNP	O
and  	and  	 CC	O
p.S218P 	p.S218P 	 CD	O
)  	)  	 -RRB-	O
that  	that  	 WDT	O
were  	were  	 VBD	O
identified  	identified  	 VBN	O
in  	in  	 IN	O
HSD3B2 	HSD3B2 	 CD	O
.  	.  	 .	O
Both  	Both  	 DT	O
Y190  	Y190  	 NNP	B-NP
and  	and  	 CC	O
S218  	S218  	 NNP	B-NP
are  	are  	 VBP	O
conserved  	conserved  	 VBN	O
among  	among  	 IN	O
mammals 	mammals 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
mutant  	mutant  	 JJ	B-NP
proteins  	proteins  	 NNS	I-NP
had  	had  	 VBD	O
severely  	severely  	 RB	O
impaired  	impaired  	 VBN	O
residual  	residual  	 JJ	B-NP
enzymatic  	enzymatic  	 JJ	I-NP
activity  	activity  	 NN	I-NP
in  	in  	 IN	O
vitro 	vitro 	 NN	B-NP
,  	,  	 ,	O
although  	although  	 IN	O
both  	both  	 DT	O
mutants  	mutants  	 NN	B-NP
retained  	retained  	 VBD	O
higher  	higher  	 JJR	O
activity  	activity  	 NN	O
for  	for  	 IN	O
17-OH  	17-OH  	 CD	O
pregnenolone  	pregnenolone  	 NN	O
than  	than  	 IN	O
for  	for  	 IN	O
the  	the  	 DT	O
other  	other  	 JJ	O
Δ5-steroids 	Δ5-steroids 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
three-dimensional  	three-dimensional  	 JJ	B-NP
model  	model  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
enzyme  	enzyme  	 NN	I-NP
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
known  	known  	 JJ	O
structures  	structures  	 NNS	O
of  	of  	 IN	O
similar  	similar  	 JJ	O
proteins 	proteins 	 NNS	O
,  	,  	 ,	O
both  	both  	 DT	O
mutations  	mutations  	 NN	O
were  	were  	 VBD	O
located  	located  	 VBN	O
extremely  	extremely  	 RB	O
close  	close  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
predicted  	predicted  	 VBN	O
substrate-binding  	substrate-binding  	 JJ	O
pocket 	pocket 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
suggests  	suggests  	 VBZ	O
that  	that  	 IN	O
the  	the  	 DT	O
mutations  	mutations  	 NN	O
can  	can  	 MD	O
cause  	cause  	 VB	O
a  	a  	 DT	O
local  	local  	 JJ	O
conformational  	conformational  	 JJ	B-NP
change  	change  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
substrate-binding  	substrate-binding  	 JJ	O
pocket 	pocket 	 NN	O
,  	,  	 ,	O
leading  	leading  	 VBG	O
to  	to  	 TO	O
alterations  	alterations  	 VB	O
of  	of  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
affinities  	affinities  	 NNS	O
for  	for  	 IN	O
Δ5-steroids 	Δ5-steroids 	 CD	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
identified  	identified  	 VBD	O
two  	two  	 CD	O
novel  	novel  	 NN	B-NP
missense  	missense  	 NN	I-NP
mutations  	mutations  	 NNS	I-NP
of  	of  	 IN	O
HSD3B2  	HSD3B2  	 NNP	O
that  	that  	 WDT	O
resulted  	resulted  	 VBD	O
in  	in  	 IN	O
unbalanced  	unbalanced  	 JJ	O
residual  	residual  	 JJ	B-NP
enzymatic  	enzymatic  	 JJ	I-NP
activities  	activities  	 NNS	I-NP
for  	for  	 IN	I-NP
Δ5-steroids 	Δ5-steroids 	 CD	I-NP
.  	.  	 .	O
As  	As  	 IN	O
a  	a  	 DT	O
potential  	potential  	 JJ	B-NP
novel  	novel  	 NN	I-NP
mechanism 	mechanism 	 NN	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
propose  	propose  	 VBP	O
that  	that  	 IN	O
the  	the  	 DT	O
mutations 	mutations 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
differently  	differently  	 RB	O
affect  	affect  	 VB	O
the  	the  	 DT	O
activity  	activity  	 NN	O
towards  	towards  	 IN	O
different  	different  	 JJ	O
substrates 	substrates 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
these  	these  	 DT	O
mutations  	mutations  	 NNS	O
provide  	provide  	 VBP	O
novel  	novel  	 JJ	O
insights  	insights  	 NNS	O
into  	into  	 IN	O
the  	the  	 DT	O
pathophysiology  	pathophysiology  	 NN	B-NP
of  	of  	 IN	O
3β-HSDD 	3β-HSDD 	 CD	O
.  	.  	 .	O
